Crossmark

Understanding the Essentialities in Establishing the Bioequivalence of Oral Inhalation Drug Products to be Marketed in the USA

Crossref DOI link: https://doi.org/10.1007/s43441-019-00007-3

Published Online: 2019-12-06

Published Print: 2020-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fernandes, Swapnil Dylan

Koland, Marina
License Information

Text and Data Mining valid from 2019-12-06
More Information

Article History

Received: 21 May 2019

Accepted: 27 September 2019

First Online: 6 December 2019

Compliance with Ethical Standards

:

: The authors confirm that the article content has no conflict of interest.